✦ LIBER ✦

Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)

✍ Scribed by Makoto Kubo, Noriko Kanaya, Karineh Petrossian, Jingjing Ye, Charles Warden, Zheng Liu, Reiki Nishimura, Tomofumi Osako, Masayuki Okido, Kazuo Shimada, Masato Takahashi, Peiguo Chu, Yate-Ching Yuan, Shiuan Chen

Book ID: 118796817
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 900 KB
Volume: 137
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-2332-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of the novel histone deacetyla

Influence of the novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer

✍ L. Garrett; L. Zhang; L. Guo; V. Therrien; W. Growdon; R. Foster; B. Rueda 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 93 KB

604 POSTER Effect of the histone deacety

604 POSTER Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor dependent human lung cancer cells

✍ E. Haura; A. Edwards; K. Bhalla 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 66 KB

The prostate cancer blocking potential o

The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258

✍ Stefan Vallo,Jens Mani,Matthias Stastny,Jasmina Makarević… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 365 KB

The histone deacetylase inhibitor, suber

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL

✍ Lisa M. Butler; Vasilios Liapis; Stelios Bouralexis; Katie Welldon; Shelley Hay; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 958 KB

## Abstract While the apoptosis‐inducing ligand Apo2L/TRAIL is a promising new agent for the treatment of cancer, the sensitivity of cancer cells for induction of apoptosis by Apo2L/TRAIL varies considerably. Identification of agents that can be used in combination with Apo2L/TRAIL to enhance apopt

Inactivation of NF-κB by proteasome inhi

Inactivation of NF-κB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells

✍ Josep Domingo-Domènech; Raffaella Pippa; Marian Tápia; Pere Gascón; Oriol Bachs; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 441 KB

Histone deacetylase inhibitor entinostat

Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin

✍ Shah, Preeti; Gau, Yael; Sabnis, Gauri 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 892 KB